RENESSA FOR STRESS URINARY INCONTINENCE
The Renessa treatment is a non-surgical approach to treating stress urinary incontinence, typically performed in a physician's office.
RENESSA® RADIOFREQUENCY ENERGY TREATMENT
The Renessa treatment is a non-surgical approach to treating Stress Urinary Incontinence (SUI), typically performed in a physician’s office. During treatment, the physician passes a small catheter-like device into the urethra. The device generates low temperature heat in small areas at the base of the bladder. Once treatment is complete, the device is removed. There are no incisions and no foreign materials of any kind are left inside the body. The heat causes the natural collagen in the tissue to become firmer, increasing the bladder’s ability to resist leaks during activity. Only a local anesthetic for numbing is needed, so patients are typically comfortable during the procedure. Recovery is rapid. Many women return to normal activities the same day.
Clinical studies have shown that nearly 3 out of 4 women are dry or improved following the Renessa® treatment, and close to 60% eliminate use of pads. A long-term study has shown that results of a single treatment last for at least 3 years. If conservative therapy and/or symptom management aren’t enough, the Renessa®treatment can be an option for women before surgery. Treatment with Renessa does not prevent a woman from having a subsequent surgical treatment for incontinence. More information can be found at www.renessa.com.
Insurance Note. As your advocate, NAFC has contacted many national and regional insurance companies about the need for non-surgical options for women with stress urinary incontinence and specifically have made them aware of the availability of the Renessa®treatment. Several of the insurers have responded positively, while others have responded that their present position is that “transurethral radiofrequency tissue remodeling for stress urinary incontinence is experimental and investigational.” We want you to be aware that use of the phrase “experimental and investigational” may be used by insurance companies to convey that they are in the assessment phase of a new technology and are not yet ready to classify it as “payable” for all of their members. Usually the insurers want to see long-term clinical results (3-5 years) published before they consider the treatment for universal coverage and payment. Typically, this does not mean that the treatment is experimental or unsafe. If you are considering this procedure, contact your insurance provider to find out whether or not it is covered at this time.